Pulmonary Vascular Medicine

Appointments & Referrals: 858-657-7100

CBS 8: UC San Diego's lifesaving pulmonary thromboendarterectomy (PTE) surgery

Advanced Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Pulmonary vascular diseases affect the blood vessels between the heart and the lungs. UC San Diego Health System is an internationally recognized referral center for the evaluation and treatment of patients with chronic thromboembolic pulmonary vascular disease and all forms of pulmonary hypertension.

Our Pulmonary Vascular Medicine program conducts research and offers one-stop for diagnosis, consultation and state-of-the-art treatment for patients with all forms of pulmonary vascular disease. Led by Nick H. Kim, MD, the program emphasizes leading-edge treatments in pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). Both PAH and CTEPH are rare and deadly, but also treatable. Read more about these services through the links below.

Pulmonary Arterial Hypertension (PAH)

Leadership in PAH Treatment:

  • State-of-the-art facilities to evaluate and diagnose all forms of pulmonary hypertension
  • Significant involvement in the clinical development of all FDA-approved therapeutics for pulmonary hypertension
  • Ongoing participation in major pulmonary hypertension clinical trials, offering patients the newest and best therapeutics available

Learn more about PAH treatment

Chronic Thromboembolic Pulmonary Hypertension

Worldwide Referral Center for CTEPH:

  • Designated Center of Excellence by the American College of Chest Physicians for the treatment of chronic thromboembolic pulmonary hypertension
  • The highest success rate in the world for pulmonary thromboendarterectomy (PTE)
  • Perform more PTEs than any other medical center in the world (over 3,000 to date)

Learn more about CTEPH treatment

Contact the Experts


Our Specialists

Meet our Pulmonary Vascular Disease Treatment Team

Breaking News

Grant Gives New Breath to Patients Suffering from Severe Pulmonary Hypertension. More on CTEPH Registry